从烯中生物合成2-乙醇,使用工程Escherichia coli全细胞
Tianzhen Xiong1, Qiuyue Gao2, Wei Liu3
1Dabie Mountain Laboratory, College of Tea and Food Science, Xinyang Normal University, Xinyang, Henan 464000, China; Henan Key Laboratory of Tea Plant Biology, College of Tea and Food Science, Xinyang Normal University, Xinyang, Henan 464000, China.
Enzyme and microbial technology
|January 11, 2025
概括
研究人员在大肠杆菌中开发了一种高效的多酶途径,用于从烯中产生2-乙醇. 优化酶表达和反应条件显著提高了2-乙醇产量和生产效率.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 酶催化酶的催化作用
背景情况:
- 2-乙醇是一种有价值的芳香醇,在化品,食品和药品中具有应用.
- 当前的生产方法可能在效率或可持续性方面存在局限性.
- 开发新的生物催化路径对于工业应用至关重要.
研究的目的:
- 通过使用全细胞生物催化剂,设计一种高效的多酶级联路径,从烯中生产2-乙醇.
- 通过酶表达平衡和反应条件调整来优化该途径.
- 建立一个强大的,高产的生物工艺,用于合成2-乙醇.
主要方法:
- 在大肠杆菌中构建一个多酶通路,涉及 styrene monooxygenase A (styA),styrene monooxygenase B (styB),styrene oxide isomerase (SOI),酒精脱酶 (yahK) 和葡萄糖脱酶 (gdh).
- 使用不同副本数量的等离子体优化酶表达水平.
- 优化全细胞转化反应参数,包括pH和温度.
- 发酵和全细胞生物转化实验.
主要成果:
- 通过途径酶的过度表达,初始产生6.28mM的2-乙醇.
- 通过平衡酶表达,产量增加63.7%,达到10.28mM.
- 优化反应条件 (pH 7.5,35°C) 导致在10小时内最终产生48.17毫米的2-乙醇.
- 展示一个高效的生物催化工艺.
结论:
- 在大肠杆菌中成功设计了一种有效的多酶级联通路,用于从氨酸中生产2-乙醇.
- 平衡酶表达和优化反应条件显著提高了产品产量和生产力.
- 开发的全细胞生物工艺为工业生产2-乙醇提供了有前途的基础.
相关概念视频
Biosynthesis in Bacteria
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


